Tandem Diabetes Care Reports Second Quarter 2016 Financial Results, Updates 2016 Guidance and Announces New t:slim X2™ Insulin Pump and Associated Technology Upgrade Program

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. META
4. SPY
5. FDX
6. IBM
7. MU
8. ACN
9. USO
10. NVDA

Go back to Tandem Diabetes Care Reports Second Quarter 2016 Financial Results, Updates 2016 Guidance and Announces New t:slim X2™ Insulin Pump and Associated Technology Upgrade Program

Tandem Diabetes (TNDM) Tops Q2 EPS by 5c

July 28, 2016 5:26 PM EDT

Tandem Diabetes (NASDAQ: TNDM) reported Q2 EPS of ($0.60), $0.05 better than the analyst estimate of ($0.65). Revenue for the quarter came in at $23 million versus the consensus estimate of $23.08 million.

GUIDANCE:

Tandem Diabetes sees FY2016 revenue of $105-110 million, versus the consensus of... More